Business
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that management will present and participate in one-on-one meetings with investors at the H.C. Wainwright 27th Annual Global Investment Conference at the Lotte New York Palace Hotel in New York, NY on September 8, 2025.
About this update from Cytosorbents Corporation
[{"type":"text","content":"PRINCETON, N.J., Sept. 5, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that management will present and participate in one-on-one meetings with investors at the H.C. Wainwright 27th Annual Global Investment Conference at the Lotte New York Palace Hotel in New York, NY on September 8, 2025.","length":468,"tagName":"p"},{"type":"image","alt":"CytoSorbents Logo","displaySize":"","headline":null,"caption":"CytoSorbents Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":185,"url":"https://media.zenfs.com/en/prnewswire.com/b4e40fc6bf504369f3cf531c16ebd1e1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/58cg8CJ60JGP9dOImePaTQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTMyNjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b4e40fc6bf504369f3cf531c16ebd1e1","width":400,"height":185}}},{"type":"text","content":"Presentation Details:Date: Monday, September 8, 2025Time: 11:30 AM ETLive webcast link: H.C. Wainwright / CytoSorbents","length":121,"tagName":"p"},{"type":"text","content":"A replay of the webcast will be archived for up to 90 days at https://ir.cytosorbents.com/events-presentations/ following the session date.","length":149,"tagName":"p"},{"type":"text","content":"About CytoSorbents Corporation (NASDAQ: CTSO)","length":45,"tagName":"p"},{"type":"text","content":"CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. CytoSorbents' proprietary blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Cartridges filled with these beads can be used with standard blood pumps already found in hospitals (e.g. dialysis, continuous renal replacement therapy or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are removed, and then back into the body. CytoSorbents' technologies are used in a number of broad application...